Bausch Health Becomes 22nd Drugmaker to End or Loosen 340B Contract Pharmacy Restrictions in Arkansas

Drugmaker Bausch Health has exempted all Arkansas covered entities from its 340B contract pharmacy restrictions in response to a state law recently upheld by a federal appeals court.
Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Issues Refunds to 340B Providers for 28 Drugs

Drugmaker Takeda is offering rebates to 340B providers on 28 of its drugs.
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Attorneys Expect Many Filings under Newly Reconstituted 340B Dispute Resolution Process

Kyle Vasquez, an attorney for Polsinelli, said he expects a "wave of filings" under HRSA's latest ADR rule because it is more flexible than the prior process.
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products

Drugmaker Novartis has announced it will refund 340B providers for more than 100 products after adjusting their 340B ceiling prices.
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Providers Generally Supportive, PhRMA Pans Final 340B Dispute Resolution Rule

After HHS released the long-awaited final rule for resolving 340B administrative disputes, provider groups generally supported and PhRMA denounced the updated process.
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, BI Agree to Lift 340B Contract Pharmacy Restrictions in Arkansas, Making It 21 Manufacturers to End or Loosen Restrictions

Boehringer Ingelheim became one of the latest major drugmakers to exempt Arkansas covered entities from its 340B contract pharmacy restrictions.
Drugmakers AbbVie and Boehringer Ingelheim (BI) have agreed in principle to exempt Arkansas providers from their 340B contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Adds Biologic to Contract Pharmacy Restrictions

Pharmaceutical giant Merck has added a new medication for pulmonary arterial hypertension to its 340B contract pharmacy restrictions.
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers

Federal officials have released the long-awaited final rule for the 340B Administrative Dispute Resolution process.
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

White House Completes Review of Final Rule for 340B Dispute Process, Release Expected Soon

The Department of Health and Human Services is expected to soon release its final 340B administrative dispute resolution rule after the White House completed its final review this week.
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Asks Full Appeals Court to Rehear Arkansas 340B Contract Pharmacy Case

PhRMA has asked the full panel of judges on the U.S. 8th Circuit Court of Appeals to rehear a case on Arkansas' 340B contract pharmacy access law.
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report